| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.10B | +11.9% |
| Cost of Revenue | $1.88B | +10.3% |
| R&D Expense | $2.06B | +19.4% |
| SG&A Expense | $1.19B | -41.5% |
| Operating Income | $2.55B | +68.2% |
| Pre-tax Income | $3.33B | +58.5% |
| Income Tax | $683.0M | +125.4% |
| Net Income | $2.65B | -44.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.86B | -0.1% |
| Short-term Investments | $3.75B | +17.2% |
| Current Assets | $17.18B | +4.1% |
| Total Assets | $20.96B | +1.5% |
| Current Liabilities | $10.16B | +2.1% |
| Long-term Debt | $2.00B | +0.2% |
| Total Liabilities | $12.55B | +0.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.52B | +16.3% |
| Investing Cash Flow | -$616.0M | +40.9% |
| Financing Cash Flow | -$3.57B | -47.0% |
| Stockholders' Equity |
| $8.41B |
| +3.0% |